(Q34669207)

3 August 2017

1 reference

title

Review article: maintenance of remission in ulcerative colitis (English)

1 reference

3 August 2017

1 reference

Kamm MA

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Alimentary Pharmacology & Therapeutics

3 August 2017

published in

1 reference

3 August 2017

volume

16 Suppl 4

1 reference

3 August 2017

page(s)

21-24

1 reference

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.4.X

Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.4.X

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.4.X

Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.4.X

Intravenous cyclosporin in ulcerative colitis: a five-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.4.X

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.4.X

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.4.X

10.1046/J.1365-2036.16.S4.4.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference